SYK:NYE-Stryker Corporation (USD)

EQUITY | Medical Devices | New York Stock Exchange

Last Closing

USD 364.6

Change

0.00 (0.00)%

Market Cap

USD 41.39B

Volume

3.15M

Analyst Target

USD 217.70
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Stryker Corp is a medical technology company. The Company offers medical technologies, including reconstructive, medical and surgical, and neurotechnology and spine products.

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-12-22 )

Largest Industry Peers for Medical Devices

Symbol Name Price(Change) Market Cap
ABT Abbott Laboratories

+0.08 (+0.07%)

USD 200.50B
MDT Medtronic PLC

+0.37 (+0.46%)

USD 103.90B
ZBH Zimmer Biomet Holdings Inc

-0.30 (-0.28%)

USD 21.51B
STE STERIS plc

+0.51 (+0.25%)

USD 21.31B
GMED Globus Medical

+0.47 (+0.57%)

USD 11.25B
SNN Smith & Nephew SNATS Inc

-0.12 (-0.49%)

USD 10.75B
PEN Penumbra Inc

-1.99 (-0.82%)

USD 9.31B
BIO Bio-Rad Laboratories Inc

+0.89 (+0.27%)

USD 9.17B
BIO-B Bio-Rad Laboratories Inc

N/A

USD 9.16B
GKOS Glaukos Corp

-2.52 (-1.67%)

USD 8.32B

ETFs Containing SYK

CIB0:XETRA VanEck Bionic Engineering.. 10.61 % 0.00 %

-0.10 (-0.22%)

USD 4.87M
UMDV:SW iShares US Medical Device.. 10.25 % 0.00 %

N/A

N/A
CYBG:LSE VanEck Bionic Engineering.. 9.94 % 0.00 %

-0.02 (-0.22%)

N/A
JGRW Trust For Professional Ma.. 6.01 % 0.00 %

+0.01 (+-0.22%)

USD 0.07B
FHI:CA CI Health Care Giants Cov.. 5.63 % 0.75 %

-0.15 (-0.22%)

CAD 0.08B
CWS AdvisorShares Focused Equ.. 4.28 % 0.68 %

-0.52 (-0.22%)

USD 0.18B
GOAI:PA Amundi Stoxx Global Artif.. 4.25 % 0.00 %

-0.09 (-0.22%)

USD 0.94B
GOAI:XETRA Amundi Stoxx Global Artif.. 4.25 % 0.00 %

-0.16 (-0.22%)

USD 0.98B
XDG3:XETRA Xtrackers MSCI Global SDG.. 4.24 % 0.00 %

-0.02 (-0.22%)

USD 0.14B
MHCD:CA Middlefield Healthcare Di.. 4.04 % 0.00 %

+0.06 (+-0.22%)

CAD 0.16B
AGNG Global X Aging Population.. 3.08 % 0.00 %

+0.16 (+-0.22%)

USD 0.06B
FOHW:XETRA Franklin Future of Health.. 2.56 % 0.00 %

-0.06 (-0.22%)

USD 2.68M
DRUP GraniteShares ETF Trust -.. 2.41 % 0.00 %

+0.48 (+-0.22%)

USD 0.06B
MEDTE:PA BNP Paribas Easy ECPI Glo.. 2.37 % 0.00 %

-0.04 (-0.22%)

N/A
MTUSD:PA BNP Paribas Easy ECPI Glo.. 2.37 % 0.00 %

+0.12 (+-0.22%)

N/A
XMLH:F Legal & General Ucits Etf.. 1.81 % 0.00 %

+0.23 (+-0.22%)

USD 0.07B
DOCT:SW L&G Healthcare Breakthrou.. 1.81 % 0.00 %

-0.05 (-0.22%)

USD 0.07B
DOCG:LSE L&G Healthcare Breakthrou.. 1.79 % 0.00 %

-3.50 (-0.22%)

USD 0.07B
DOCT:LSE L&G Healthcare Breakthrou.. 1.79 % 0.00 %

+0.04 (+-0.22%)

USD 0.07B
IHI iShares U.S. Medical Devi.. 0.00 % 0.43 %

+0.06 (+-0.22%)

N/A
LNGR 0.00 % 0.50 %

N/A

N/A
FHI-B:CA CI Health Care Giants Cov.. 0.00 % 0.00 %

N/A

CAD 0.05B
LIFE:CA Evolve Global Healthcare .. 0.00 % 0.69 %

+0.22 (+-0.22%)

CAD 0.21B
GOAI:F Amundi Index Solutions - .. 0.00 % 0.00 %

N/A

N/A
XMLH:XETRA L&G Healthcare Breakthrou.. 0.00 % 0.00 %

-0.07 (-0.22%)

USD 0.07B
TACE 0.00 % 0.00 %

N/A

N/A
TDOC:CA TD Global Healthcare Lead.. 0.00 % 0.00 %

+0.16 (+-0.22%)

CAD 0.09B

Market Performance

  Market Performance vs. Industry/Classification (Medical Devices) Market Performance vs. Exchange (New York Stock Exchange)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 21.75% 74% C 80% B-
Dividend Return 1.07% 57% F 17% F
Total Return 22.82% 77% C+ 78% C+
Trailing 12 Months  
Capital Gain 22.55% 74% C 80% B-
Dividend Return 1.34% 57% F 22% F
Total Return 23.90% 74% C 79% B-
Trailing 5 Years  
Capital Gain 72.32% 83% B 82% B
Dividend Return 6.90% 63% D 19% F
Total Return 79.22% 83% B 80% B-
Average Annual (5 Year Horizon)  
Capital Gain 13.24% 65% D 72% C
Dividend Return 14.36% 65% D 70% C-
Total Return 1.13% 50% F 27% F
Risk Return Profile  
Volatility (Standard Deviation) 24.88% 77% C+ 44% F
Risk Adjusted Return 57.73% 87% B+ 72% C
Market Capitalization 41.39B N/A N/A N/A N/A

Key Financial Ratios

  Ratio vs. Industry/Classification (Medical Devices) Ratio vs. Market (New York Stock Exchange)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
Market Value  
Price / Earning Ratio 25.40 N/A N/A
Price/Book Ratio N/A N/A N/A
Price / Cash Flow Ratio N/A N/A N/A
Price/Free Cash Flow Ratio N/A N/A N/A
Management Effectiveness  
Return on Equity N/A N/A N/A
Return on Invested Capital N/A N/A N/A
Return on Assets N/A N/A N/A
Debt to Equity Ratio N/A N/A N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

Low volatility

The stock’s annual returns have been stable and consistent compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile. Although stability is good, also keep in mind it can limit returns.

What to not like:
Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.

Low Dividend Growth

This stock has shown below median dividend growth in the previous 5 years compared to its sector.